Navigation Links
deCODE and SGENE Consortium Discover Deletions in the Human Genome Linked to Risk of Schizophrenia
Date:7/30/2008

CODE T2(TM) for type 2 diabetes; deCODE AF(TM) for atrial fibrillation and stroke; deCODE MI(TM) for heart attack; deCODE ProCa(TM) for prostate cancer; and deCODE Glaucoma(TM) for a major type of glaucoma. deCODE is delivering on the promise of the new genetics.(SM) Visit us on the web at http://www.decode.com; on our diagnostics website at http://www.decodediagnostics.com; and, for our pioneering personal genome analysis service, at http://www.decodeme.com.

Any statements contained in this presentation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, and the timing of events, to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to our ability to obtain financing and to form collaborative relationships, uncertainty regarding potential future deterioration in the market for auction rate securities which could result in additional permanent impairment charges, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, inc
'/>"/>

SOURCE deCODE genetics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
2. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
3. deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
4. deCODE Obesity Study Sheds Light on How Genetics Affects Risk and Onset of Common Diseases
5. deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer
6. Marketing of Diagnostics and deCODEme(TM), Recent Progress in Drug Development to be Highlighted at deCODE R&D Event
7. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
8. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
9. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
10. Childrens Brain Tumor Foundations Tissue Bank Consortium May Solve Dire Problem in Pediatric Cancer Research
11. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- International, well-known,scientific experts were surprised ... mg/day),data presented as "extremely promising."[1] More ... clinicians critically reviewed these data.,These experts ... lipid-modifying,treatments, fenofibrate and bezafibrate, in treating ... patients with metabolic syndrome,and type 2 ...
(Date:12/16/2009)... 16 RealMed has been ranked ... the 2009 Top 20 Best in ... report. RealMed is a dynamic revenue cycle ... processing between healthcare providers and all ... firm specializing in vendor performance measurement in ...
(Date:12/16/2009)... WALTHAM, Mass., Dec. 16 According to ... medical technology market intelligence, health care reforms in ... stent market in 2009, and will continue to ... new Asia Pacific Markets for Interventional Cardiology ... by the Chinese government will allow the Chinese ...
Breaking Medicine Technology:International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 3RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 2RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 3Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 2Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 3Drinking Weight Depression Linked in Young Women 3A Study 57563 1Drinking Weight Depression Linked in Young Women 3A Study 57563 2Childhood Stroke More Common Than Thought 57559 1Childhood Stroke More Common Than Thought 57559 2Childhood Stroke More Common Than Thought 57559 3Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations 57557 1Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations 57557 2Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations 57557 3
... Sept. 19 Women with postmenopausal,osteoporosis receiving ... in bone mineral density (BMD) to those,receiving ... new,study presented at the 29th Annual Meeting ... Research. The study, called MOTION (Monthly ...
... CHICAGO, Sept. 19 Targanta Therapeutics Corporation,today ... the in vitro,activity of its lead antibiotic ... against a variety of susceptible and resistant ... presented today at the 47th,Annual Interscience Conference ...
Other Medicine Technology:New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis 2New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis 3New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis 4Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria 2Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria 3Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria 4Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria 5
(Date:12/16/2009)... shows, , , WEDNESDAY, Dec. 16 (HealthDay News) -- Average ... 78 years, a record high, federal health officials said ... to live to 80.4 years on average and men ... U.S. Centers for Disease Control and Prevention. , ... than their parents, life expectancy in the United States ...
(Date:12/16/2009)... 16 OrthoAccel Technologies, Inc., developers of ... acceleration device to enhance orthodontics, announced Alison Davies ... UK. Ms. Davies has spent the last ... dental industry, most recently for nine years as ... makers of Invisalign . ,, ...
(Date:12/16/2009)... A new software program developed by CareRise ... facilities to calculate their staffing needs as it relates ... allows inpatient healthcare facilities to calculate their mandatory nurse-to-patient ... and receive a daily report as to how it ... leader in risk management in the healthcare industry, has ...
(Date:12/16/2009)... MassMutual,s Retirement Services Division has announced ... platform in Q2 2010. The new platform will ... investment change materials in a variety of themes. ... from a menu of creative options to support ... population. The new RetireSmart participant engagement platform will ...
(Date:12/16/2009)... FRANCISCO, Dec. 16 Quantros, Inc., a ... professional services solutions for the healthcare industry, announces ... division. Quantros has named software industry veteran Michael ... Tulloch will work from the company,s new Marlborough, ... is a natural one," explains Tulloch. "Quantros has ...
Breaking Medicine News(10 mins):Health News: Life Expectancy in U.S. Hits New High 2Health News: Life Expectancy in U.S. Hits New High 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4Health News:United States Patent Office Allows CareRise Patent on 24/7 Staff-Census Software 2Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 2Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 3Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 4Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 5Health News:Safety and Quality Software Developer Quantros, Inc. Launches Healthcare IT Consulting Division 2
... Governance Joins RiskMetrics and Glass Lewis in Urging Stockholders ... Inc. (Nasdaq: LCAV ) announces that the ... RiskMetrics Group,s ISS Governance Services and Glass Lewis & ... retain the Company,s current management and Board of Directors ...
... 11 Universal Capital Management, Inc. (OTC ... development company that provides management and strategic ... pleased to announce that one of its ... Professional Healthcare Billing Services (PHB) located in ...
... Nausea and Vomiting (PONV)CORONA DEL MAR, Calif., March 11 ... patient,s oxygen status known on a beat-by-beat basis. Not ... say that all patients should have this monitor. No ... ASA Newsletter on their web site between 1983 and ...
... bystanders," platelets may actually play a more sinister role in organ ... ... (Vocus) March 11, 2009 -- Scientists at Children,s National Medical ... in patients suffering from sepsis: platelets. , , , , ,The ...
... Orthopedic research studies have concluded that inexpensive off-the-shelf ... arch pain due to over-pronation than costly custom-made ... savings for a large segment of the population. ... in partnership with Footlogics Australia, have designed a ...
... Dr. William Groff will perform a PPP laser procedure ... Check local listings for airtime. SANTA CLARA, Calif., March ... seller of laser, light-based and radio-frequency devices for surgical, ... laser will be featured on The Doctors national television ...
Other Medicine News:Health News:Three Leading Proxy Advisory Firms are Unanimous in Recommending LCA-Vision Stockholders Support the Current Board of Directors 2Health News:Three Leading Proxy Advisory Firms are Unanimous in Recommending LCA-Vision Stockholders Support the Current Board of Directors 3Health News:Three Leading Proxy Advisory Firms are Unanimous in Recommending LCA-Vision Stockholders Support the Current Board of Directors 4Health News:iVolution Medical Systems Acquires Professional Healthcare Billing Services 2Health News:iVolution Medical Systems Acquires Professional Healthcare Billing Services 3Health News:American Society of Anesthesiologists (ASA) - Myths About 'Never Ending Pursuit of Patient Safety and Satisfaction' Debunked 2Health News:Children's National Research Links Platelets to Sepsis-Related Organ Failure 2Health News:Children's National Research Links Platelets to Sepsis-Related Organ Failure 3Health News:Millions in Potential Health Care Savings: Prefab Orthotics Found More Effective 2Health News:Millions in Potential Health Care Savings: Prefab Orthotics Found More Effective 3Health News:Millions in Potential Health Care Savings: Prefab Orthotics Found More Effective 4Health News:Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papule (PPP) Procedure 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: